Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × Quality of Life × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 11 Breast Neoplasms 10 Prostatic Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Gastrointestinal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Brain Neoplasms 3 Sarcoma 2 Pain 2 Oligodendroglioma 2 Multiple Myeloma 2 Hematologic Neoplasms 2 Glioma 2 Glioblastoma 2 Fatigue 2 Esophageal Neoplasms 2 Carcinoma, Hepatocellular 2 Ascites 2 Weight Loss 1 Uterine Cervical Neoplasms 1 To Observe Whether the Fucoidan Can Improve the Quality of Life of the Such Patients Receiving the Neoadjuvant CCRT 1 Thymus Neoplasms 1 Thrombocytopenia 1 Symptom Management 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Splenomegaly 1 Speech 1 Sexual Dysfunction, Physiological 1

Interventions

Nivolumab 15 Surveys and Questionnaires 7 Ipilimumab 7 linrodostat 5 Standard of Care 5 Paclitaxel 5 Bevacizumab 5 temsirolimus 4 Sirolimus 4 Interviews as Topic 4 Gemcitabine 4 Docetaxel 4 relatlimab 3 Vorinostat 3 Pemetrexed 3 Erlotinib Hydrochloride 3 Cetuximab 3 Carboplatin 3 ARRY-334543 3 regorafenib 2 apatinib 2 abemaciclib 2 Trastuzumab 2 Sunitinib 2 Sorafenib 2 Olanzapine 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01444157 2014-07-18

FamCope

Bispebjerg Hospital

Phase 3 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡